J&J recollects child powder after hint asbestos present in bottle

Johnson & Johnson on Friday recalled a single batch of its child powder as a precaution after authorities testing discovered hint quantities of asbestos in a single bottle purchased on-line.

The recalled lot consists of 33,000 bottles which had been distributed final 12 months.

J&J stated the U.S. Meals and Drug Administration discovered minuscule quantities of asbestos in a single bottle throughout routine testing and notified the corporate on Thursday. J&J stated it instantly started investigating with the FDA.

“The FDA’s testing on prior events, and as lately as final month, discovered no asbestos,” stated spokesman Ernie Knewitz.

J&J stated it was checking the place the bottles had been shipped, if the examined bottle is counterfeit or genuine and whether or not the pattern may need been contaminated throughout testing.

The recall comes as J&J fights hundreds of lawsuits during which plaintiffs declare its iconic child talcum powder was contaminated with asbestos and that it prompted ovarian most cancers or mesothelioma, a uncommon most cancers linked to inhaling asbestos fibers.

At a number of trials, J&J’s skilled witnesses have testified asbestos hasn’t been detected within the talc in its child powder in hundreds of checks over the past 40 years. A number of juries have reached multimillion-dollar verdicts in opposition to the corporate, almost all of that are being appealed or have been overturned on attraction.

Talc, the softest of minerals, is mined from deposits all over the world, which will be contaminated with asbestos. J&J says the corporate and its talc suppliers routinely check their talc to make sure there is not any asbestos. The talc is then crushed right into a white powder and purified to be used in private care merchandise to soak up moisture.

The recalled lot of 22-ounce bottles is #22318RB. Shoppers who’ve a bottle from that lot ought to cease utilizing it; refunds can be found via the corporate’s web site .

The corporate’s shares dropped 5% to $129.33 at noon Friday, following the recall information and, only a day earlier, the announcement of a $117 million settlement with 41 states over allegations the corporate deceptively marketed its pelvic mesh merchandise by concealing dangers.


Comply with Linda A. Johnson at https://twitter.com/LindaJ—onPharma


The Related Press Well being and Science Division receives assist from the Howard Hughes Medical Institute’s Division of Science Schooling. The AP is solely liable for all content material.

Supply hyperlink